CYSTEINE RESIDUES IN THE VIF PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE ESSENTIAL FOR VIRAL INFECTIVITY

被引:58
|
作者
MA, XY
SOVA, P
CHAO, W
VOLSKY, DJ
机构
[1] ST LUKES ROOSEVELT HOSP,MOLEC VIROL LAB,NEW YORK,NY 10019
[2] COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032
关键词
D O I
10.1128/JVI.68.3.1714-1720.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The infectivity factor of human immunodeficiency virus type 1 (HIV-1), Vif, contains two cysteine residues which are highly conserved among animal lentiviruses. We introduced substitutions of leucine for cysteine residues in the vif gene of a full-length HIV-1 clone to analyze their roles in viral infection. Mutant viruses containing substitutions in either Cys-114, Cys-133, or both displayed a vif-negative infection phenotype similar to that of an isogeneic vif deletion mutant, namely, a cell-dependent complete to partial loss of infectivity. The vif defect could be complemented by cotransfection of mutant viral DNA with a Vif expression vector, and there was no evidence that recombination contributed to the repair of the vif deficiency. The viral protein profile, as determined by immunoblotting, in cells infected with cysteine substitution mutants and that in wild-type virus were similar, including the presence of the 23-kDa Vif polypeptide. In addition, immunoblotting with an antiserum directed against the carboxyl terminus of gp41 revealed that gp41 was intact in cells infected with either wild-type or vif mutant HIV-1, excluding that Vif cleaves the C terminus of gp41. Our results indicate that the cysteines in HIV-1 Vif are critical for Vif function in viral infectivity.
引用
收藏
页码:1714 / 1720
页数:7
相关论文
共 50 条
  • [21] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [22] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715
  • [23] INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PEDERSEN, C
    DANISH MEDICAL BULLETIN, 1994, 41 (01) : 12 - 22
  • [24] ROLE OF CONSERVED GP41 CYSTEINE RESIDUES IN THE PROCESSING OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE PRECURSOR AND VIRAL INFECTIVITY
    SYU, WJ
    LEE, WR
    DU, B
    YU, QC
    ESSEX, M
    LEE, TH
    JOURNAL OF VIROLOGY, 1991, 65 (11) : 6349 - 6352
  • [25] LECTIN CARBOHYDRATE INTERACTIONS AND INFECTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)
    GATTEGNO, L
    RAMDANI, A
    JOUAULT, T
    SAFFAR, L
    GLUCKMAN, JC
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (01) : 27 - 37
  • [26] ABERRANT GAG PROTEIN-COMPOSITION OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF MUTANT - PRODUCED IN PRIMARY LYMPHOCYTES
    SIMM, M
    SHAHABUDDIN, M
    CHAO, W
    ALLAN, JS
    VOLSKY, DJ
    JOURNAL OF VIROLOGY, 1995, 69 (07) : 4582 - 4586
  • [27] VIRAL-DNA CARRIED BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRIONS
    LORI, F
    VERONESE, FD
    DEVICO, AL
    LUSSO, P
    REITZ, MS
    GALLO, RC
    JOURNAL OF VIROLOGY, 1992, 66 (08) : 5067 - 5074
  • [28] NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY COMPLEMENT OCCURS BY VIRAL LYSIS
    SPEAR, GT
    SULLIVAN, BL
    LANDAY, AL
    LINT, TF
    JOURNAL OF VIROLOGY, 1990, 64 (12) : 5869 - 5873
  • [29] THE CENTRAL GLOBULAR DOMAIN OF THE NUCLEOCAPSID PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS CRITICAL FOR VIRION STRUCTURE AND INFECTIVITY
    OTTMANN, M
    GABUS, C
    DARLIX, JL
    JOURNAL OF VIROLOGY, 1995, 69 (03) : 1778 - 1784
  • [30] MUTATIONAL ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV TRANSACTIVATOR - ESSENTIAL RESIDUES NEAR THE AMINO TERMINUS
    HOPE, TJ
    MCDONALD, D
    HUANG, XJ
    LOW, J
    PARSLOW, TG
    JOURNAL OF VIROLOGY, 1990, 64 (11) : 5360 - 5366